This trade activity should not be overlooked: Amylyx Pharmaceuticals Inc (AMLX)

With 0.83 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.85 million shares. The 52-week range on AMLX shows that it touched its highest point at $7.27 and its lowest point at $1.58 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at -0.52.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMLX was up-trending over the past week, with a rise of 23.92%, but this was down by -1.84% over a month. Three-month performance dropped to -24.95% while six-month performance rose 57.38%. The stock lost -80.34% in the past year, while it has lost -1.32% so far this year. A look at the trailing 12-month EPS for AMLX yields -4.43 with Next year EPS estimates of -1.88. For the next quarter, that number is -0.50. This implies an EPS growth rate of 54.70% for this year and 6.15% for next year. EPS is expected to grow by 25.21% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -78.71%.

Float and Shares Shorts:

At present, 68.63 million AMLX shares are outstanding with a float of 64.38 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMLX since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$4.16082 being high and -$4.43349 being low. For AMLX, this leads to a yearly average estimate of -$4.3325. Based on analyst estimates, the high estimate for the next quarter is -$0.57 and the low estimate is -$0.57. The average estimate for the next quarter is thus -$0.57.